The highest estimate is 23.00. From 4 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Satellos Bioscience Inc., a regenerative medicine company, develops therapeutics to treat degenerative muscle diseases. Its lead program focuses on the development of oral therapeutic drug to correct muscle stem cell polarity and restore the body's innate muscle repair and regeneration process. The company was incorporated in 2012 and is headquartered in Toronto, Canada.
The current price of MSCLF is $12.14 USD — it has increased by +5.11% in the past 24 hours. Watch Satellos Bioscience stock price performance more closely on the chart.
What is Satellos Bioscience stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTCM exchange Satellos Bioscience stocks are traded under the ticker MSCLF.
Is Satellos Bioscience stock price growing?▼
MSCLF stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Satellos Bioscience has showed a +113.21% increase.
What is Satellos Bioscience market cap?▼
Today Satellos Bioscience has the market capitalization of 2.25B
What is Satellos Bioscience revenue for the last year?▼
Satellos Bioscience revenue for the last year amounts to 0 USD.
What is Satellos Bioscience net income for the last year?▼
MSCLF net income for the last year is -39.99M USD.
How many employees does Satellos Bioscience have?▼
As of September 06, 2026, the company has 14 employees.
In which sector is Satellos Bioscience located?▼
Satellos Bioscience operates in the Health & Wellness sector.
When did Satellos Bioscience complete a stock split?▼
The last stock split for Satellos Bioscience was on January 30, 2026 with a ratio of 1:12.
Where is Satellos Bioscience headquartered?▼
Satellos Bioscience is headquartered in Toronto, United States.